EICHORCondition: Dermatomyositis · Polymyositis · Sponsor: EMD Serono Research & Development Institute, Inc.
The purpose of this study is to evaluate the efficacy and safety of orally administered M5049 in idiopathic inflammatory myopathies, specifically dermatomyositis (DM) and polymyositis (PM) participants for 24 weeks.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Neuromuscular Research Center | Phoenix, Arizona, United States | — |
| HonorHealth Research Institute - Bob Bove Neuroscience Institute-Neuroscience Research | Scottsdale, Arizona, United States | — |
| Mayo Clinic Scottsdale (6365) | Scottsdale, Arizona, United States | — |
| Barbara Davis Center | Aurora, Colorado, United States | — |
| HMD Research LLC | Orlando, Florida, United States | — |
| Bolanos Clinical Research | Pembroke Pines, Florida, United States | — |
| Augusta University-Rheumatology | Augusta, Georgia, United States | — |
| Johns Hopkins University - Department of Medicine, Division of Rheumatology | Baltimore, Maryland, United States | — |
| University of Minnesota-Dermatology | Minneapolis, Minnesota, United States | — |
| University of Kansas Medical Center-Neuromuscular | Kansas City, Missouri, United States | — |
| University of Pittsburgh | Pittsburgh, Pennsylvania, United States | — |
| Austin Neuromuscular Center | Austin, Texas, United States | — |
+ 19 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05650567